LY2605541--a preferential hepato-specific insulin analogue

Diabetes. 2014 Feb;63(2):390-2. doi: 10.2337/db13-1646.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Glucose / metabolism*
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • Insulin Lispro / pharmacology*
  • Insulins / pharmacology*
  • Liver / drug effects*
  • Liver / metabolism*
  • Polyethylene Glycols / pharmacology*

Substances

  • Hypoglycemic Agents
  • Insulin Lispro
  • Insulins
  • LY2605541
  • Polyethylene Glycols
  • Glucose